Cargando…

Effects of liraglutide on obesity-associated functional hypogonadism in men

Lifestyle measures (LSMs) should be the first-line approach offered for obesity-related functional hypogonadism (FH). When LSMs fail, the role of testosterone replacement treatment (TRT) is unclear. GLP1 receptor agonist liraglutide is linked to progressive and sustained weight loss. A potential dir...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jensterle, M, Podbregar, A, Goricar, K, Gregoric, N, Janez, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6391904/ https://www.ncbi.nlm.nih.gov/pubmed/30707677 http://dx.doi.org/10.1530/EC-18-0514

Ejemplares similares

SUN-221 Effects of Liraglutide on Obesity-Associated Functional Hypogonadism in Men: A Randomized, Testosterone Replacement Treatment-Controlled Study
por: Jensterle Sever, Mojca, et al.
Publicado: (2019)

Metformin as an initial adjunct to low-dose liraglutide enhances the weight-decreasing potential of liraglutide in obese polycystic ovary syndrome: Randomized control study
por: JENSTERLE, MOJCA, et al.
Publicado: (2016)

Short-term effectiveness of low dose liraglutide in combination with metformin versus high dose liraglutide alone in treatment of obese PCOS: randomized trial
por: Jensterle, Mojca, et al.
Publicado: (2017)

The prevalence and characteristics of non-functioning and autonomous cortisol secreting adrenal incidentaloma after patients’ stratification by body mass index and age
por: Podbregar, Ana, et al.
Publicado: (2020)

Sexual and Reproductive Outcomes in Obese Fertile Men with Functional Hypogonadism after Treatment with Liraglutide: Preliminary Results
por: La Vignera, Sandro, et al.
Publicado: (2023)

Natural history of nonfunctioning adrenal incidentalomas: a 10-year longitudinal follow-up study
por: Podbregar, Ana, et al.
Publicado: (2021)

Semaglutide in Obesity: Unmet Needs in Men
por: Jensterle, Mojca, et al.
Publicado: (2023)

Long-term efficacy of metformin in overweight-obese PCOS: longitudinal follow-up of retrospective cohort
por: Jensterle, Mojca, et al.
Publicado: (2019)

An impaired glucagon-like peptide-1 response is associated with prediabetes in polycystic ovary syndrome with obesity
por: Ferjan, Simona, et al.
Publicado: (2019)

Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study
por: Jensterle, Mojca, et al.
Publicado: (2015)

Short-term combined treatment with liraglutide and metformin leads to significant weight loss in obese women with polycystic ovary syndrome and previous poor response to metformin
por: Jensterle Sever, Mojca, et al.
Publicado: (2014)

Effects of metformin withdrawal after long and short term treatment in PCOS: observational longitudinal study
por: Kravos, Nika Aleksandra, et al.
Publicado: (2021)

Genetic Variability in Antioxidative and Inflammatory Pathways Modifies the Risk for PCOS and Influences Metabolic Profile of the Syndrome
por: Herman, Rok, et al.
Publicado: (2020)

Impact of COVID-19 Pandemic on Disease Control Status and Quality of Life of Patients with Acromegaly
por: Herman, Rok, et al.
Publicado: (2022)

Obesity Surgery Improves Hypogonadism and Sexual Function in Men without Effects in Sperm Quality
por: Miñambres, Inka, et al.
Publicado: (2022)

SLC6A4 5HTTLPR Polymorphism Affects Insulin Secretion in Patients with Polycystic Ovary Syndrome
por: Šenk, Barbara, et al.
Publicado: (2018)

Depression in Nonclassical Hypogonadism in Young Men
por: Korenman, Stanley G, et al.
Publicado: (2018)

Features of steroidogenesis in men with hypogonadism and type 2 diabetes
por: Rozhivanov, R. V., et al.
Publicado: (2022)

Metabolic endotoxaemia related inflammation is associated with hypogonadism in overweight men
por: Tremellen, Kelton, et al.
Publicado: (2017)

Hypogonadotropic hypogonadism in men with hereditary hemochromatosis
por: El Osta, Rabih, et al.
Publicado: (2017)

Induction of spermatogenesis in men with hypogonadotropic hypogonadism
por: Morris, Guy C., et al.
Publicado: (2021)

Serum concentrations of dihydrotestosterone are associated with symptoms of hypogonadism in biochemically eugonadal men
por: Sansone, A., et al.
Publicado: (2021)

The effectiveness of zinc supplementation in men with isolated hypogonadotropic hypogonadism
por: Liu, Yan-Ling, et al.
Publicado: (2017)

Cognitive effects of testosterone and finasteride administration in older hypogonadal men
por: Borst, Stephen E, et al.
Publicado: (2014)

Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men
por: Maseroli, E., et al.
Publicado: (2020)

Side Effects Associated with Liraglutide Treatment for Obesity as Well as Diabetes
por: Seo, Young-Gyun
Publicado: (2021)

Clomiphene Citrate in the Management of Infertility in Oligospermic Obese Men with Hypogonadism: Retrospective Pilot Study
por: Panner Selvam, Manesh Kumar, et al.
Publicado: (2023)

Liraglutide restores impaired associative learning in individuals with obesity
por: Hanssen, Ruth, et al.
Publicado: (2023)

Visceral fat dysfunction is positively associated with hypogonadism in Chinese men
por: Wang, Ningjian, et al.
Publicado: (2016)

Association between hypertriglyceridemic waist phenotype and hypogonadism in Taiwanese adult men
por: Wang, Sheng-Kuang, et al.
Publicado: (2022)

Hypogonadism in Human Immunodeficiency Virus-Positive Men
por: Ashby, Jane, et al.
Publicado: (2014)

Recommendations on the diagnosis, treatment and monitoring of hypogonadism in men
por: Lunenfeld, Bruno, et al.
Publicado: (2015)

Obesity and Baseline Estradiol Levels Are Independent Predictors for Initiation of Anastrozole in Hypogonadal Men on Clomiphene Citrate
por: Keihani, Sorena, et al.
Publicado: (2020)

PMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
por: Jayasena, Channa, et al.
Publicado: (2022)

Liraglutide pharmacokinetics and exposure‐response in adolescents with obesity
por: Carlsson Petri, Kristin C., et al.
Publicado: (2021)

Functional hypogonadism in adolescence: an overlooked cause of secondary hypogonadism
por: Esquivel-Zuniga, Rebeca, et al.
Publicado: (2023)

A Perspective on Middle-Aged and Older Men With Functional Hypogonadism: Focus on Holistic Management
por: Grossmann, Mathis, et al.
Publicado: (2017)

Efficacy and safety of liraglutide in Indian adolescents with obesity
por: Kochar, I. S., et al.
Publicado: (2019)

Morning free and total testosterone in HIV-infected men: implications for the assessment of hypogonadism
por: Monroe, Anne K, et al.
Publicado: (2014)

A bidirectional relationship between metabolic syndrome and hypogonadism in men
por: Bandgar, TR, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_99kp9omck9jrehsbp9pbjovgv2